Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the beginning of 2018. Several of the CTS client forms specify list the Medical Director in the header and these forms will be updated on March 5, 2018. Check out the Communication page for a complete list of forms or by clicking the link below: Communications
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...